Investigation of the catalytic mechanism of Mycoplasma pneumoniae L-alpha-glycerophosphate oxidase: mutation of the proposed catalytic base by Crowley, Craig Matthew & NC DOCKS at Western Carolina University
INVESTIGATION OF THE CATALYTIC MECHANISM OF MYCOPLASMA PNEUMONIAE 
L-ALPHA-GLYCEROPHOSPHATE OXIDASE: MUTATION OF THE PROPOSED 
CATALYTIC BASE  
 
 
A thesis presented to the faculty of the Graduate School of Western Carolina University in 
partial fulfillment of the requirements for the degree of Master of Science in Chemistry 
 
By 
 
Craig Matthew Crowley II 
 
Director: Dr. Jamie R. Wallen 
Assistant Professor of Chemistry 
Department of Chemistry & Physics 
 
Committee Members: Dr. Jack Summers, Chemistry 
Dr. Robert Youker, Biology  
 
June 2016 
  
ii 
 
ACKNOWLEDGEMENTS 
 
I would foremost like to thank my research advisor Dr. Jamie Wallen for his constant 
mentoring and encouragement throughout my time at Western Carolina University.  His 
expertise, patience and understanding added considerably to my graduate experience.   
 I would like to thank the other members of my committee, Dr. Jack Summers and Dr. 
Robert Youker for their assistance that they provided at all levels of the research project.  Their 
valuable insight throughout my project was helpful and always welcome.   
 I’d like to thank Wes Bintz for his help with finding the necessary materials and ordering 
anything required throughout my research project.   
 I would also like to thank my family for the support they provided me though my entire 
life and in particular, I must acknowledge my wife and best friend, Regan, without whose love, 
encouragement and editing assistance, I would not have finished this thesis.    
  
iii 
 
TABLE OF CONTENTS 
 
 
 
LIST OF TABLES ......................................................................................................................... iv 
 
LIST OF FIGURES .........................................................................................................................v 
 
LIST OF ABBREVIATIONS ........................................................................................................ vi 
 
ABSTRACT .................................................................................................................................. vii 
 
CHAPTER 1. BACKGROUND .....................................................................................................1 
1.1 INTRODUCTION TO FLAVOENZYMES ........................................................................1 
1.2 L-ALPHA-GLYCEROPHOSPHATE OXIDASES ............................................................5 
1.3 MYCOPLASMA PNEUMONIAE .......................................................................................11 
 
CHAPTER 2. INTRODUCTION TO RESEARCH .....................................................................20 
 
CHAPTER 3. EXPERIMENTAL .................................................................................................21 
3.1 MATERIALS .....................................................................................................................21 
3.2 METHODS ........................................................................................................................21 
3.2.1 GENETIC ENGINEERING METHODS ..............................................................21 
3.2.2 EXPRESSION AND PURIFICATION OF HIS6-MPGLPO ................................22 
3.2.3 ENZYME ASSAY .................................................................................................23 
3.2.4 STEADY-STATE KINETICS ...............................................................................24 
3.2.5 SULFITE TITRATION ASSAY ...........................................................................25 
3.2.6 PH TITRATION USING MULTI-BUFFER SYSTEMS ......................................26 
3.2.7 EXPRESSION OF SSPGLPO ...............................................................................27 
 
CHAPTER 4. RESULTS AND DISCUSSION ............................................................................28 
4.1 EXPRESSION AND PURIFICATION OF HIS6-MPGLPO  ...........................................28 
4.2 ENZYME ASSAY .............................................................................................................31 
4.3 STEADY-STATE KINETICS ...........................................................................................34 
4.4 SULFITE TITRATION ASSAY .......................................................................................36 
4.5 PH TITRATION USING MULTI-BUFFER SYSTEMS ..................................................40 
4.6 EXPRESSION OF SSPGLPO ...........................................................................................41 
 
CHAPTER 5. CONCLUSIONS AND FUTURE WORK ............................................................44 
 
CHAPTER 6. WORKS CITED ....................................................................................................48 
 
 
 
 
  
iv 
 
LIST OF TABLES 
 
 
 
Table 1: Reactions catalyzed by flavin-dependednt enzymes .........................................................3 
Table 2: Thermodynamic and kinetic parameters of the His6-MpGlpO reaction ..........................13 
 
  
v 
 
LIST OF FIGURES 
 
 
 
Figure 1: An image of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) ......2 
Figure 2: Process of hydrogen peroxide (H2O2) signaling pathway activation ...............................4 
Figure 3: Reaction catalyzed by GlpO .............................................................................................6 
Figure 4: Reaction of GlpO flavin with sulfite and a hydride ion ...................................................7 
Figure 5: Ping-pong mechanism where the substrate A binds to the enzyme, enzyme-substrate 
complex EA forms ..........................................................................................................9 
Figure 6: Comparisons of the MpGlpO structure and sequence with select homologs .................10 
Figure 7: Proposed overall catalytic reaction of His6-MpGlpO .....................................................12 
Figure 8: Three-dimensional structure of the MpGlpO determined by x-ray crystallography ......14 
Figure 9: This figure shows the most recent model of glycerophosphate (Glp) binding, with the 
Glp substrate that has been modeled in shown in green. ..............................................15 
Figure 10: Schematic drawing of residues involved in substrate binding and catalysis in MpGlpO 
and EcGlpD ..................................................................................................................16 
Figure 11: Overlay of the Streptococcus species GlpO (magenta) with the MpGlpO crystal 
structure (green) using PyMol ......................................................................................18 
Figure 12: Schematic of how horseradish peroxidase uses the H2O2 generated from the MpGlpO-
catalyzed reaction to oxidize reduced ABTS to generate oxidized ABTS ...................24 
Figure 13: Standards of the size-exclusion column .......................................................................29 
Figure 14: This figure illustrates the chromatogram taken during the gel filtration column of 
MpGlpO wild-type .......................................................................................................29 
Figure 15: Chromatogram of mutant H51A of the gel filtration column ......................................30 
Figure 16: Chromatogram of mutant S348A of the gel filtration column .....................................30 
Figure 17: Standard kinetic assay for wild-type, H51A, H51Q & S348A MpGlpOs monitored at 
25 oC .............................................................................................................................32 
Figure 18: Apparent steady-state kinetic parameters of wild-type MpGlpO at 25 oC ...................35 
Figure 19: Sulfite titrations of MpGlpO wild-type ........................................................................37 
Figure 20: Sulfite titrations of MpGlpO mutant H51Q .................................................................38 
Figure 21: Sulfite titrations of MpGlpO mutant S348A ................................................................39 
Figure 22: pH titration of MpGlpO wild-type enzyme using Britton Robinson Buffer, at 25 oC, at 
various pHs to test specific activity ..............................................................................41 
Figure 23: SDS-PAGE gel of SspGlpO protein fractions after Q column (cation exchange) .......42 
 
  
vi 
 
LIST OF ABBREVIATIONS 
 
 
 
ABTS………2,2’–azino-bis(3–eth-ylbenzothiazoline-6–sulfonic acid) 
BPACE…….boric acid, phosphoric acid, citric acid & EDTA 
BTZs……….1,3-benzothiazin-4-one 
DHAP………dihydroxyacetone phosphate 
EDTA………ethylenediaminetetraacetic acid 
FAD………..flavin adenine dinucleotide 
FMN……….flavin mononucleotide 
Glp…………glycerophosphate 
GlpD……….glycerophosphate dehydrogenase 
GlpK……….glycerophosphate kinase 
GlpO……….glycerophosphate oxidase 
H2O2 ………hydrogen peroxide 
HRP………..horseradish peroxidase 
kcat………….measure of the catalytic production of product under optimum conditions 
Kd…………..dissociation constant 
Km………….michaelis-menten constant  
K2HPO4……potassium phosphate monobasic 
LB………….lysogeny broth 
pKa………..acid dissociation constant 
ROS……….reactive oxygen species 
[S]………….substrate concentration 
SDS-PAGE…….sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TYP………..tryptone yeast phosphate media 
UV/Vis…….ultraviolet-visible spectroscopy 
V…………..velocity 
V0………….initial velocity 
Vmax............maximal velocity 
vii 
 
ABSTRACT 
 
INVESTIGATION OF THE CATALYTIC MECHANISM OF MYCOPLASMA PNEUMONIAE 
L-ALPHA-GLYCEROPHOSPHATE OXIDASE: MUTATION OF THE PROPOSED 
CATALYTIC BASE  
Craig Matthew Crowley, M.S. in Chemistry 
Western Carolina University (June 2016) 
Director: Dr. Jamie R Wallen, Ph.D.  
 
The formation of hydrogen peroxide (H2O2) by the enzyme L-alpha-glycerophosphate oxidase 
(MpGlpO) is essential for the pathogenesis of Mycoplasma pneumoniae.  M. pneumoniae is a 
pathogen that targets the human respiratory tract, causing at least 40% of all pneumoniae 
infections, with the most common symptom being tracheobronchitis in children.  MpGlpO relays 
electrons from L-alpha-glycerophosphate to molecular oxygen to form the products 
dihydroxyacetone phosphate and hydrogen peroxide.  Because the formation of hydrogen 
peroxide is essential for M. pneumoniae pathogenesis, the MpGlpO enzyme has emerged as a 
potential therapeutic target for pneumoniae infections.  Recently an X-ray crystal structure of the 
apo form MpGlpO was determined.  Based on features of the proposed active site, a model of 
glycerophosphate binding was proposed.  This study is focused on mutating amino acids that are 
predicted from the model to bind the glycerophosphate substrate to confirm their role in the 
catalytic cycle.  We were especially interested in investigating the hypothesis that a catalytic 
base is required for deprotonation of the glycerophosphate substrate, in particular if the histidine 
residue was essential for catalysis.  MpGlpO wild-type and mutants H51A, H51Q, and S348A 
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proteins were expressed and purified from E. coli resulting in 22, 2, 11 and 21 mg of protein 
respectively from 4.8 liters of Terrific Broth.  The activity of the purified enzymes were 
determined by a ABTS-HRP coupled assay to be 34.7 +/- 4.6 U*mg-1, 0.45 +/- 0.18 U*mg-1, 
2.22 +/- 0.34 U*mg-1 and 0.62 +/- 0.22 U*mg-1 for wild-type, H51A, H51Q, and S348A 
respectively.  Our results, and the results of our collaborators, indicate that the reaction can still 
proceed without a catalytic base, but we have identified histidine 51 and serine 348 as having 
important roles in hydrogen bonding the glycerophosphate substrate in the MpGlpO reaction. 
Reactivity of the mutants indicates that neither residue acts as the essential base.  Future work 
will focus on understanding the contribution of other residues in the active site that are predicted 
to bind the substrate. 
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CHAPTER 1. BACKGROUND 
 
1.1 INTRODUCTION TO FLAVOENZYMES 
Oxidation of reduced flavin by molecular oxygen (O2) is a very important reaction in 
biochemistry.  In vivo, flavins generally exist in the form of flavin mononucleotide (FMN), 
which is riboflavin phosphorylated at the 5’-OH of the ribityl chain, and flavin adenine 
dinucleotide (FAD), which is the condensation product of FMN and AMP (Figure 1).1  Flavins 
are redox cofactors, capable of receiving up to two electrons from reducing substrates and 
relaying them to electron acceptors.  The flavin coenzymes FMN and FAD catalyze a wide 
variety of redox and monooxygentation reactions on diverse classes of compounds (Table 1).2  
Both forms of flavin appear to be functionally equivalent, but some enzymes use FMN, others 
use FAD, and some utilize both.2  Only about 5-10% of flavoenzymes have a covalently linked 
FAD, though in most cases these enzymes have a higher redox potential than enzymes that do 
not.3  Oxygen is readily available in aerobic organisms and is commonly utilized as an electron 
acceptor in flavoenzyme catalysis, generating hydrogen peroxide (H2O2), which has emerged as 
an important regulator of signal transduction in eukaryotic organisms.4   
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Figure 1: An image of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) 
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Table 1: Reactions catalyzed by flavin-dependent enzymes2 
 
 
Another reason that the reaction of flavoenymes remains an active area of research is that 
flavoenzyme oxidases are active generators of reactive oxygen species (ROS).  ROS are oxygen 
containing reactive chemical species that are currently being researched in biochemistry studies 
because of their involvement in ageing, the process of deteriorating with age, and pathological 
conditions such as cancer and neurodegeneration.4  Hydrogen peroxide (H2O2), the superoxide 
anion, and the hydroxyl radical are key members of the class of ROS, which are generated via 
the respiratory chain cascade but also as byproducts of cellular metabolism4.  In contrast to the 
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hydroxyl radical and superoxide anion, the less reactive H2O2 is involved in many physiological 
processes such as mediating immune responses, hypoxic signal transduction, and cell 
differentiation and proliferation.5  However, its effects depend on the local concentration, 
cellular context, and exposure time within the cell (Figure 2).6  Therefore, H2O2 is no longer 
observed as an unwanted toxic byproduct, but is now considered as having an important role in 
the control of cellular processes.5   
 
 
Figure 2: Process of hydrogen peroxide (H2O2) signaling pathway activation6 
 
Many flavoenzymes are important for cellular redox metabolism and homeostasis, and 
some flavin-dependent oxidases are well-known drug targets.  One example of an FAD-
dependent enzyme that regulates metabolism is glycerol-3-phosphate dehydrogenase, which is 
involved in triglyceride synthesis.  An example of a FAD-dependent oxidase used as a drug 
target is decaprenylphosphroyl-beta-D-ribose, a flavin-dependent enzyme involved in cell wall 
biosynthesis which has been targeted as a strategy to kill Mycoplasma tuberculosis.4  Inhibition 
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of this enzyme halts the formation of decaprenylphosphroyl arabinose, a key precursor required 
for the synthesis of the cell-wall arabinans, thus initiating cell lysis and eventually causing 
bacterial death.7  Makarov et al synthesized and characterized 1,3-benzothiazin-4-ones (BTZs), a 
new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and 
in mouse models of tuberculosis.7   
 
1.2 L-ALPHA-GLYCEROPHOSPHATE OXIDASES 
The FAD-linked oxidation of alpha-glycerophosphate (Glp) to dihydroxyacetone 
phosphate (DHAP) occurs in at least three different types of enzymes.  The first two are alpha-
glycerophosphate dehydrogenases (GlpDs) from mitochondria (mitoGlpD8) and from bacteria 
(bactGlpD9), homologous enzymes having sequences that are approximately 33% identical.10  
The third FAD-dependent Glp-oxidizing enzyme is alpha-glycerophosphate oxidase (GlpO), 
which is found primarily in heme-deficient lactic acid bacteria such as Enterococcus 
casseliflavus (formerly Streptococcus faecium).11,12  GlpOs are further characterized into type I 
and type II based on their catalytic mechanisms.  Type I and type II GlpO differ in their substrate 
recognition residues and the distinction between the type I and type II GlpO active sites offers 
the opportunity to design inhibitors that can selectively block the activity of type II enzymes 
such as MpGlpO while at the same time not inhibit activity of type I enzymes such of the 
mitochondrial Glp dehydrogenase of the host.13  GlpOs are homologous with the bacterial and 
mitochondrial GlpDs, having sequences approximately 30-43% identical with them but they are 
distinguished by an insert that is roughly 50 residues long. This insert falls between two 
segments and interacts with the Glp substrate.14  A previous study done by Charrier et al15 
reported that the GlpO insert represents a flexible region on the protein surface.  Enzyme-
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monitored turnover analyses of the GlpO without the insert demonstrated a 20-fold increase in 
the Km(Glp), indicating that the flexible surface region of the is involved in an important role in 
mediating efficient flavin reduction by assisting with Glp binding.15   
Functionally, GlpO differs from GlpD in that GlpO efficiently catalyzes reduction of O2 
to H2O2 while GlpD does not, with the E. casseliflavus enzyme having a kcat/Km(O2) of ~ 106M-
1s-1.14  Also GlpO is clearly a cytosolic protein while GlpD is membrane bound.12  A GlpO 
enzyme is also similar to a GlpD enzyme in that both enzymes will oxidize the glycerophosphate 
substrate, but an oxidase only uses oxygen as it’s electron acceptor while GlpD is able to utilize 
various compounds as its electron acceptor.  The most efficient electron acceptor for E. coli 
GlpD is potassium ferricyanide.9  GlpO catalyzes the oxidation of L-alpha-glycerophosphate 
(Glp) at the C2 position to create dihydroxyacetone phosphate as a product.  Molecular oxygen 
(O2) acts as an electron acceptor during this reaction by receiving two electrons from the flavin 
of GlpO to generate H2O2 (Figure 3).  The hydrogen peroxide produced by this reaction is a 
reactive oxygen species that may be converted to more potent ROS such as peroxide or hydroxyl 
radicals, and the hydrogen peroxide itself may serve as a cellular signaling molecule.16  ROS 
affect cell viability by causing lysis of red blood cells, lipid peroxidation and other oxidative 
damage.17   
 
 
Figure 3: Reaction catalyzed by GlpO 
 
Similarly to their fundamentally different reactivities toward oxygen, flavoprotein 
oxidases and dehydrogenases also offer a vast contrast in their reactivity with sulfite.14  All 
7 
 
oxidases stabilize flavin N(5)-sulfite adducts, but no sulfite reaction is observed within the 
dehydrogenases.14  It was noted by Parsonage et al., that the reaction sequence leading to the 
nucleophilic addition of sulfite to the flavin N(5)-position parallels very similarly with the 
addition of a hydride ion (H-) to the GlpO flavin (Figure 4).14  It is possible to use the results 
obtained from sulfite titrations to determine which residues could be involved in the addition of 
the hydride ion to the GlpO flavin.    
 
 
Figure 4: Reaction of GlpO flavin with sulfite and a hydride ion14 
 
While all GlpDs are membrane-associated, it is not clear in some cases whether they are 
integral or peripheral membrane proteins.10  For example, the mammalian mitoGlpD has been 
localized to the outer surface of the inner membrane,10 but a separate re-study of the enzyme 
predicts it to be an integral membrane protein with three transmembrane helices.8  Likewise, E. 
coli GlpD was first reported to require detergent for solubilization during purification, which 
could lead to the conclusion that it would be an integral membrane protein, but later a His-tagged 
version of the E.coli GlpD was purified without the use of detergent.10  Another recent study 
concluded that E.coli GlpD was an integral membrane protein with “six transmembrane spanning 
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regions”18.  The Bacillus subtillis GlpD is found predominantly in the cytosolic fraction 
following ultracentrifugation of glycerol-grown cell extracts.19 
Studies of GlpOs from several bacteria have already been accomplished.10,14  Due to the 
lack of a GlpO enzyme in mammalian cells the enzyme has become a proposed target for new 
antibacterial treatment in many organisms.  One example of analyzing GlpOs is a native GlpO 
from Trypanosoma brucei, a human parasite that is known for causing African sleeping sickness, 
was isolated, purified and analyzed to study how to inhibit the enzyme.20  The study revealed that 
some potent inhibitors of T. brucei GlpO are suramin and alkyl esters of 3,4-dihydroxybenzoic 
acid.20  Fairlamb et al. discovered that increasing the length of the alkyl substituent resulted in 
greater inhibition of the GlpO enzyme.  They proposed that the inhibitor acts via competition 
with ubiquinol for the oxidase, with the aromatic regions of the inhibitor forming stable charge-
transfer complexes with the alkyl chains of the oxidase that mimic the isoprenoid side chain of 
ubiquinol.20  GlpO from lactic acid bacteria such as Streptococcus species and Streptococcus 
faecium ATCC 12755 have also been studied11,12.  Studies on inhibition of the enzyme revealed 
that S. faecium GlpO was inhibited by 25 mM fructose 6-phosphate.11    
A study of the recombinant GlpO from Enteroccocus casseliflavus indicated that the 
reaction (Scheme 2) obeys a ping-pong (double-displacement) kinetic model, and that the rate-
limiting step in the overall reaction is the flavin-reduction.14  In a ping-pong kinetic model, the 
enzyme bounces back and forth from an intermediate state (E*) to its original state. The ping-
pong mechanism is characterized by the change into an intermediate form when the first 
substrate to product reaction occurs.  Another key characteristic of the ping-pong mechanism is 
that one product (P) is formed and released before the second substrate (B) binds (Figure 5).   
 
9 
 
 
Figure 5: Ping-pong mechanism where the substrate A binds to the enzyme, enzyme-substrate 
complex EA forms.  At this point, the intermediate state, E* forms.  Product (P) is released from 
E*, then B binds to E*, B is converted to Q which is then released as the second product.  E* 
becomes E, and the process gets repeated. 14  
 
In contrast, kinetics studies of the Streptococcus species wild-type GlpO and a mutant 
enzyme which had a flexible surface region truncated indicated that the release of DHAP was the 
rate-limiting step of the enzymatic reaction.15  This suggests that GlpO enzymes utilize distinct 
catalytic mechanisms, which leads to the separation between type I and type II GlpOs.  Although 
type I and type II GlpOs are similar in function, they only share less than 20% sequence identity 
with each other.  The visual overlay of the flavin region of MpGlpO, SspGlpO and E. coli GlpD 
(Figure 6A) and the entire structure overlay of MpGlpO and SspGlpO (Figure 6B) shows the 
divergence between the two groups of enzymes.   
A structure-based sequence alignment of these proteins (Figure 6C) provides further 
details of the comparisons, and is useful for noticing the similarities and differences in the active 
site residues.13  Both the type I and type II GlpOs, SspGlpO and MpGlpO, have histidine residues 
in the active site predicted to interact with the glycerophosphate substrate, as well as an 
absolutely conserved arginine residues predicted to bind the phosphate moiety of the substrate.  
One of the major differences in the active site residues between the type I GlpO SspGlpO and the 
type II GlpO MpGlpO is the presence of a serine residue in MpGlpO that is not conserved in 
SspGlpO.   
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Figure 6: Comparisons of the MpGlpO structure and sequence with select homologs. (A) A 
flavin region overlay of MpGlpO (off-white protein and yellow FAD) and SspGlpO (blue; PDB 
code: 2RGH)4 and EcGlpD (cyan; PDB code: 2QCU)9. (B) Overlay of MpGlpO (green) and 
SspGlpO (magenta) structures. (C) Structure-based sequence alignment of MpGlpO and four 
enzyme homologs.  Conserved residues (*) and residues involved in beta strands (yellow), alpha 
helices (cyan) and 310-helices (blue) are indicated. Also highlighted are residues noted as being 
important in substrate binding (red boxes) and flavin binding (green boxes). Dots above the 
MpGlpO sequence mark every tenth residue and, at the end of each line, a residue number for 
each of the sequences is shown. Lower case letters are residues that are disordered in the 
structure.13 
 
A 
C 
B 
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1.3 MYCOPLASMA PNEUMONIAE 
M. pneumoniae is a pathogen that is known to target the human respiratory tract, causing 
at least 40% of all pneumoniae infections, with the most common symptom being 
tracheobronchitis in children.21  The pneumoniae pathogen infects its host via the mucosal 
epithelium with the use of a special attachment organelle.21  This organelle is a polar, negatively 
charged and elongated cell extension that facilitates motility and cytoadherence to cells from the 
host.21  It is composed of a central filament surrounded by an intracytoplasmic space, along with 
a number of structural and accessory proteins along with adhesins localized at the tip of the 
organelle.21  M. pneumoniae contains a small genome, lacks a rigid cell wall, and has limited 
metabolic capabilities.13  Glycerol metabolism is an important factor in pathogenicity for M. 
pneumoniae.17,22  The mycoplasmas are missing enzymes necessary for a tricarboxylic acid cycle 
and an electron transport chain as well as respiratory cytochromes.  Since glycerol is an 
important energy source for this pathogen, enzymes that are involved in glycerol metabolism 
have become potential drug targets for combating the respiratory infectious disease.  In 
particular, a gene of interest in M. pneumoniae is the MPN051, which was annotated as encoding 
for a glycerol-3-phosphate dehydrogenase (glpD).13  Despite its annotation as a dehydrogenase, a 
recent study refers to the encoded protein as a GlpO rather than GlpD due to its use of oxygen in 
the catalytic reaction and it being a cytosolic protein.13  MPN051 has been shown to be a 
constitutively expressed cytosolic FAD-dependent L-alpha-glycerophosphate oxidase.22  The 
GlpO gene is tightly linked with the gene that encodes for glycerol kinase (glpK) and, together; 
these enzymes can catalyze the ATP-dependent conversion of glycerol to DHAP.22  The 
hydrogen peroxide produced by the MpGlpO enzyme has been shown to be necessary for 
pathogenicity of the organism, and the ortholog from the animal pathogen, Mycoplasma 
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mycoides subspecies mycoides SC, has been shown as a primary virulence factor as well.11  Also, 
a study performed by Madhi et al. has shown that Streptococcus pneumoniae GlpO is 
responsible for promoting pneumococcal meningitis as well as H2O2-mediated cytotoxicity 
towards human brain microvascular endothelial cells.23   
In contrast to the behaviors observed with other GlpO enzymes, MpGlpO is able to 
catalyze the reaction of reduced enzyme with DHAP, which is the reverse of the reaction 
described in Figure 3.  This catalytic property of MpGlpO may represent a control mechanism to 
prevent excessive generation of H2O2, which may be harmful to bacterial cells.  The proposed 
overall catalytic reaction of MpGlpO is shown in Figure 7, with the values for the kinetic 
parameters seen in the figure illustrated in Table 2.  The data in Table 2 indicates that the rate 
constants of the forward reaction (k1 and k3) are much greater than reverse reaction rate constants 
(k2 and k4), indicating the reverse reaction occurs most likely at high concentrations of DHAP.16   
 
 
Figure 7: Proposed overall catalytic reaction of MpGlpO.  Two enzyme populations (fast- and 
slow-reacting species) react with substrates in both reactions.  The reverse flavin oxidation is 
indicated by red arrows.16  
13 
 
Table 2: Thermodynamic and kinetic parameters for the MpGlpO reaction. ND is not 
determined16 
 
 
A crystal structure of the MpGlpO was recently published (Figure 8) by Elkhal et al.13  
The MpGlpO chain is organized into a substrate-binding domain with a core anti-parallel, eight-
stranded beta-sheet and a FAD-binding domain with a predominantly parallel, six-stranded beta-
sheet (Figure 8).13  The crystal structure illustrates that the two domains are discontinuous, with 
the FAD-binding domains including residues 1-87, 149-219 and 330-364, while the substrate-
binding domain is formed by residues 86-148 and 227-323.13     
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Figure 8: Three-dimensional structure of the MpGlpO determined by x-ray crystallography.  The 
glycerophosphate substrate is predicted to bind near the Flavin adenine dinucleotide (FAD, 
yellow structure).13   
 
A crystal structure of the full-length Streptococcus species GlpO (SspGlpO) and the 
truncated wild-type enzyme were solved at 2.4 and 2.3 angstroms respectively.  The crystal 
structure of the type I GlpO indicates that the residues located at the active site of the enzyme 
most likely to be involved in substrate binding are polar residues such as His65, Arg 346, 
Lys429, and Arg6910,13,24.  The positively charged arginine is predicted to interact with the 
negatively charged phosphoryl group on the glycerophosphate substrate.   
The structure shown in Figure 8 is of the apo enzyme without the substrate bound and 
currently there is no structure data showing how type I (SspGlpO) or type II (MpGlpO) enzymes 
bind to Glp. Two distinct modes were proposed based on the type I and II crystal structures 
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(Figure 9).13  We believe that the MpGlpO binding method is a closer representation of the 
glycerophosphate binding mechanism than the one proposed for SspGlpO because the arginine 
320 residue, conserved in all 72 close relatives of MpGlpO (Figure 6C), is positioned so that it 
can contact the phosphate group and the glycerophosphate substrate aligns with the proposed 
catalytic base, histidine 51, also conserved in all 72 close relatives in MpGlpO (Figure 6C).  This 
predicted binding method positions the C2-hydroxyl of the Glp substrate within close proximity 
of the flavin cofactor.  For SspGlpO it was proposed that the substrate would be oriented the 
opposite way of Figure 3, with the 3’-phosphoryl moiety near the equivalent of MpGlpO His51 
and the C1-hydroxyl interacting with the equivalent of MpGlpO Arg320.10   
 
 
Figure 9: This figure shows the most recent model of glycerophosphate (Glp) binding, with the 
Glp substrate that has been modeled in shown in green.  The amino acids predicted to interact 
with Glp are shown in white, and a one letter code and number indicate each one.  Specific 
interactions between amino acids in the Glp substrate are indicated with dashed lines.  The FAD 
cofactor is shown in yellow.13   
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Based on the predicted mode of Glp binding to the MpGlpO and the EcGlpD active sites 
the electron flow during the Glp oxidation proposed to occur according to Figures 10A and 
10B.13  As indicated in Figure 10A (arrows), in MpGlpO, the substrate is in the correct position 
so that His51 can deprotonate the C2-hydroxyl, promoting the formation of a ketone and helping 
facilitate the hydride transfer from the C2-atom to the flavin N5-atom.  The proposed model of 
Glp binding also indicates that negatively-charged phosphoryl groups for substrate recognition 
are important because type I and type II enzymes have three and four positively charged side 
chains involved in its recognition, respectively (Figure 10).13   
 
 
Figure 10: Schematic drawing of residues involved in substrate binding and catalysis in MpGlpO 
(A) and EcGlpD (B).  The MpGlpO active site atoms approximately in the plane of the flavin are 
shown smaller and with thinner bonds and hydrogen bonds (dashed); atoms in front of the flavin 
are shown with thicker bonds and hydrogen bonds (dashed). Curved arrows indicate the 
proposed flow of electrons during the reductive half- reaction. (B) Similar diagram as in (A), 
showing the EcGlpD active site as a representative of a type I GlpO.13   
 
A recent study on the full kinetic reaction of MpGlpO1 combined with the structural 
results helps explain some of the differences between type I and type II enzymes.13  One 
particular area of interest was the redox potential difference between the MpGlpO flavin, which, 
A B 
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at -167 mV, is much more negative than those seen for type I GlpOs (e.g. Enterococcus 
casseliflavus GlpO at -118 mV).9,16  Although there are many factors that can influence redox 
potentials in enzymes, one clear difference in the flavin environment that explains this change in 
redox potential between the type I and type II enzymes is the fact that the type I GlpO/DH 
enzymes conserve an active site lysine (equivalent to Lys354 in EcGlpD) (Figure 6C) which has 
its amino group on the residue at van der Waals distance above the flavin N1/O2 atom. Instead of 
an active site lysine, the type II enzymes have a conserved neutral serine side chain in that 
location (equivalent to Ser348 in MpGlpO).13  An overlay of the MpGlpO active site His51 and 
Ser348 residues with SspGlpO equivalents (Figure 11) shows the difference in the flavin 
environment.   This additional local positive charge in the type I enzymes would make them 
easier to reduce.13  As noted in Maenpuen et al., the difference in redox potential is the reason 
that MpGlpO can catalyze the reverse reaction (DHAP oxidation of the reduced flavin), whereas 
the type I enzymes tested could not.16  
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Figure 11: Overlay of the Streptococcus species GlpO (magenta) with the MpGlpO crystal 
structure (green) using PyMol.  The glycerophosphate substrate that has been modeled in is 
shown in white.  Dashed lines represent hydrogen bonds between the Glp substrate and the 
amino acids.  The histidine amino acid is conserved in both enzymes, while the Ser348 residue 
that is present in MpGlpO is not present in SspGlpO.  
 
A kinetic analysis of MpGlpO has recently been completed and the steady-state kinetic 
parameters for MpGlpO were as follows: KmGlp = 5.5 mM, kcat = 4.2 s-1, and kcat/Km = 0.76 mM-
1*s-1 (at pH 7.0 and 4 oC).16  This kcat value is four- and nine-fold lower, respectively, than those 
of GlpO from Streptococcus sp. (18 s-1)15 and E. casseliflavus (37 s-1)14 at the same temperature 
(~4 oC) and pH (~7.0). The Km value for Glp in the MpGlpO reaction was determined to be 5.5 
mM, which is approximately threefold higher and fourfold lower, respectively, than those of 
Streptococcus sp. (2 mM)10 and E. casseliflavusi (24 mM)14.  The three enzymes have similar Km 
values for O2 (55 uM, 52 uM and 35 uM for MpGlpO, Streptococcus sp. and E. casseliflavius, 
respectively).10,14  Under apparent steady-state conditions (pH 7.0, 25 oC), the MpGlpO displayed 
a KmGlp = 12 +/- 1 mM, kcat = 60.1 s-1, and kcat/Km = 5 mM-1*s-1.16 These increases in kcat and 
2.8 
4.8 
2.4 
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kcat/Km when compared to the steady-state parameters are likely due to the increase in 
temperature used during the assay.   
This thesis presents a continuation of the study of the catalytic mechanism of 
Mycoplasma pneumoniae L-alpha-glycerophosphate oxidase and the effects caused by mutation 
of the proposed catalytic base His51 as well as Ser348.  This study uses a combination of sulfite 
titrations and standard kinetic assays of wild-type and mutant enzymes to understand the roles of 
these two amino acids in catalysis.  Future work will focus on identifying the importance of other 
residues predicted to bind Glp from the model in the catalytic cycle as well as comparing the 
structurally similar type I GlpO (SspGlpO) catalytic base equivalent (His65) to the His residue in 
MpGlpO.  Understanding the role of the structurally similar type I SspGlpO could provide some 
details on the catalytic base in MpGlpO.  Further study in this research could provide a solid 
foundation for guiding further studies of type I GlpOs and mitochondrial Glp dehydrogenases, as 
well as for continued studies of M. pneumoniae glycerol metabolism and the development of 
novel therapeutics targeting MpGlpO.   
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CHAPTER 2. INTRODUCTION TO RESEARCH 
 
The purpose of this research is to (1) confirm the role of amino acids in MpGlpO that are 
predicted to bind the glycerophosphate substrate, (2) identify the base necessary for 
deprotonation of the glycerophosphate substrate and (3) perform a preliminary study on 
expression of SspGlpO. 
The first goal of this study is to test the hypothesis that the amino acids His51, Arg320, 
Ser348, Phe250, Lys258, Tyr234 and Ser47 bind the glycerophosphate substrate in the MpGlpO 
enzyme.  These amino acids were mutated by site-directed mutagenesis using standard PCR 
methods.  The mutants were then expressed in bacterial cells and purified to compare their 
activity to that of the wild-type enzyme.   
The second goal of this research was to test the hypothesis that His51 is the acid-base 
catalyst in the MpGlpO reaction by mutating histidine 51 and observing the effect of this 
mutation on the activity of the enzyme. Mutants of histidine 51 were engineered using standard 
PCR protocols, bacterial expressions systems, and purified to compare against the activity of the 
wild-type enzyme.   
The third goal of this research was to express SspGlpO in order to compare the effects of 
the catalytic base mutation between type I and type II L-alpha-glycerophosphate oxidases.   
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CHAPTER 3. EXPERIMENTAL 
 
3.1. MATERIALS 
The disodium salt hydrate of FAD, horseradish peroxidase type I (HRP), the 
diammonium salt of 2,2’–azino-bis(3–eth-ylbenzothiazoline-6–sulfonic acid) (ABTS), and the 
disodium salt of DL–a–glycerophosphate (Glp) were all purchased from Sigma-Aldrich (St. 
Louis, MO, USA).  Isopropyl-beta-D-thiogalactopyranoside and all antibiotics were purchased 
from Gold Biotechnology.  All of the chromatography columns were purchased from GE 
Healthcare Biosciences.  The plasmids used were a gift from Claiborne lab at Wake Forest 
University School of Medicine.  Oligos used for mutagenesis were purchased from Integrated 
DNA Technologies (IDT).  Restriction enzymes (DpnI) and nucleotides were purchased from 
New England Biolabs Inc.  Herculase Polymerase was obtained from Stratagene.   
 
3.2. METHODS 
3.2.1. GENETIC ENGINEERING METHODS 
Mutations of the residues of interest were engineered in the gene coding for the wild-type 
MpGlpO using site-directed mutagenesis and standard PCR methods.25  Wild-type MpGlpO, 
which had been cloned into a pET28a vector, was used as the template for the mutagenesis 
reactions.  To confirm that DNA was made during the site-directed mutagenesis reaction, each 
sample was digested with DpnI to remove wild-type template then ran on a 0.8% agarose gel.  
The samples that contained DNA were then transformed into DH5 alpha cells to propagate the 
plasmid and purified using a standard miniprep kit from Qiagen.  The plasmid DNA was 
sequence in-house by Sanger sequencing to confirm the correct mutation.  All DNA samples 
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were sequenced in house using the Big Dye Terminator Kit v1.1 on a ABI 3730xl Sequencer 
(Applied Biosystem, USA) using an 80 cm capillary array for plasmid DNA or from GeneWiz 
using T7 and T7 term primers.  
 
3.2.2. EXPRESSION AND PURIFICATION OF HIS6-MpGlpO 
A streak of colonies of E. coli BL21 harboring the His6-MpGlpO expression plasmid, 
pET28a-mpglpo, was inoculated into 100 mL Terrific Broth [1.2%(w/v) peptone, 2.4%(w/v) 
yeast extract, 0.4%(v/v) glycerol, 15.6 mM KH2PO4, and 72 mM K2HPO4] (in a 500 mL 
Erlenmeyer flask) containing 50 micrograms/mL kanamycin, and placed in a shaking incubator 
at 37 oC until the optical density reached 1.0.  All colonies should have the same plasmid, but 
some cells might express better than others, so taking a selection of colonies improves the odds 
of picking a good one.  The culture was then inoculated into 5 x 800 mL Terrific broth 
containing 50 micrograms/mL kanamycin once the flask reached an optical density of ~1.0.  The 
large-scale cultures were grown at 37 oC until the absorbance at 600 nm reached 0.6-0.9.  The 
cultures were then cooled to 25 oC and were induced by addition of isopropyl-beta-D-
thiogalactopyranoside (IPTG) at a final concentration of 1 mM, and grown overnight at this 
temperature for approximately 16 hours.  Cells were harvested by centrifugation at 3500 g for 30 
minutes at 4 oC and stored at -80 oC until use.   
Harvested cells were resuspended in 50 mM sodium phosphate, pH 7.0, containing 200 
mM NaCl, 10% v/v glycerol and 10 mM imidazole.  Cells were lysed by ultrasonication using a 
Branson 250 Sonifier using seven 1-minute pulses with an output of 5 and the duty cycle set to 
constant.  The lysed cells were then centrifuged at 35,000 g for one hour and then the supernatant 
is removed, and the cells centrifuged with another high-speed spin (35,000 g) for 30 minutes 
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before being loaded onto a 5 mL Ni-NTA column pre-equilibrated with 50 mL of 50 mM sodium 
phosphate buffer, pH 7.0, containing 200 mM NaCl, 10% v/v glycerol and 10 mM imidazole.  
MpGlpO protein was eluted with 500 mM imidazole after washing the column with 50 mL 20 
mM imidazole.  The pooled yellow fractions were loaded onto a 5 mL SP-Sepharose HP column 
equilibrated in 50 mM potassium phosphate, pH 7.0, 0.5 mM EDTA and 100 mM NaCl.  The 
column was washed with 50 mM potassium phosphate, pH 7.0, 0.5 mM EDTA and 100 mM 
NaCl before MpGlpO was eluted with a 100 mM to 1 M NaCl gradient over 200 mLs.  Fractions 
were analyzed by SDS/PAGE, the fractions containing the correctly sized protein band were then 
pooled, and concentrated using an Amicron Ultra-15 Centrifugal Filter.  A solution of 1 mL of 
purified enzyme was exchanged into 50 mM potassium phosphate, pH 7.0, and 0.5 mM EDTA 
using a HiPrep 26/60 Sephacryl S-200 HR column.  The enzyme was then concentrated to less 
than 1 mL and placed into 10 microliter aliquots in microcentrifuge tubes, and kept at -80 oC 
until use.  The protein amount was determined using a NanoDrop 2000 Spectrophotometer based 
on the FAD molar extinction coefficient of 12.4 mM-1cm-1 at 450 nm.  
 
3.2.3. ENZYME ASSAY 
The activity of His6-MpGlpO was measured by monitoring the amount of H2O2 formed 
using the 2-2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)/horseradish peroxidase (ABTS-
HRP) assay system (Figure 12).16   
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Figure 12: Schematic of how horseradish peroxidase uses the H2O2 generated from the MpGlpO-
catalyzed reaction to oxidize reduced ABTS to generate oxidized ABTS, which is dark green 
with a lambda max at 420 nm and a molar absorption coefficient of 42.3 mM-1cm-1 (per mole 
Glp consumed).16 
 
HRP uses the H2O2 generated from the His6-Mp-GlpO-catalyzed reaction to oxidize 
reduced ABTS to produce oxidized ABTS, which has a dark green color with a lambda max at 
420 nm and a molar absorption coefficient of 42.3 mM-1*cm-1.26  The standard assay solution in 
50 mM sodium phosphate buffer (oxygen concentration of approximately 0.26mM), pH 7.0, 
typically contained 100 mM Glp, 1 mM ABTS and 600 nM HRP at 25 oC.  The buffer was 
saturated with oxygen by stirring the buffer with a magnetic stir-bar at high speeds overnight.  
The activity of the enzyme was measured by monitoring the increase in absorbance at 420 nm 
due to the oxidation of ABTS.  One unit of His6-MpGlpO activity was defined as the amount of 
enzyme required to oxidize 1 micromole of Glp per minute.  Specific activity of the enzyme was 
calculated by multiplying the rate of the reaction by the volume of the reaction and then dividing 
by the mass of the total protein to give units of micromole*min-1*mg-1.   
 
3.2.4 STEADY-STATE KINETICS 
Apparent steady-state kinetics analysis of the MpGlpO reaction was performed in air-
saturated 50 mM sodium phosphate buffer (saturated oxygen concentration is approximately 0.26 
mM), pH 7.0, at 25 oC at various concentrations of D,L-glycerophosphate (0.1 mM – 51.2 mM) 
using the ABTS-HRP assay.  The reactions were monitored at 420 nm as described above.  The 
reactions follow apparent steady-state kinetics because the concentrations of one substrate were 
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changed (Glp) while the other substrate (O2) stays at the same concentration.  Under these 
conditions, the enzyme behaves just like a single-substrate enzyme and gives apparent Km and 
Vmax. The initial rates were calculated using the first five seconds of the reaction and then plotted 
versus Glp concentration.  The initial rate at this time should represent the maximal rate of the 
enzyme.  Apparent kinetic parameters were calculated a Hanes-Woolf plot, where [S] is substrate 
concentration, V is initial velocity, Km is the binding affinity of enzyme for substrate and Vmax is 
the maximal velocity of the reactions.   
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3.2.5. SULFITE TITRATION ASSAY 
Many flavoprotein oxidases react with sulfite to form a reversible adduct at the flavin N5-
position.27  The reaction of sulfite with MpGlpO was measured at 450 nm; 35.4 micromolar 
enzyme (final concentration) was treated with sulfite in 0.8 mL of 50 mM potassium phosphate, 
500 mM EDTA, pH 7.0, under aerobic conditions at 25 oC.  Oxidized flavins show a high 
absorbance at 450 nm,27 as the flavin forms the sulfite-adduct the flavin is no longer oxidized 
and the 450 nm absorbance decreases.  The enzyme and buffer was titrated with a 1 M sodium 
phosphate solution, using 5-minute incubation periods, to get final sulfite concentrations of 0 to 
50 mM.  The dissociation constant for substrate binding (Kd) was determined by plotting the 
Abs450 versus sulfite concentration.  If the rate-determining enzymatic step (k2) is slow compared 
to substrate dissociation (k-1>>k2), the Michaelis constant Km is roughly the dissociation constant 
Kd of the enzyme-substrate complex.28   
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3.2.6. PH TITRATION USING MULTI-BUFFER SYSTEMS 
In order to determine the pKa of the important catalytic residues in the active site of 
MpGlpO wild-type we used a pH titration following the standard assay conditions.  Attempts at a 
pH titration of wild-type MpGlpO enzyme were used with a variety of multi-buffer systems. 
Using a multi-buffer system, buffers may be prepared at a desired pH value without altering the 
chemical composition of the buffered component.  In order to analyze the pH-dependent 
properties of MpGlpO multi-buffer systems, or universal buffers, known as the Britton-Robinson 
buffer (effective from pH 2.6 to 12), BPACE buffer, and a modified universal buffer were 
utilized.29  The Britton-Robinson buffer system contains three different buffering components: 
40 mM citric acid (pKa = 3.0, 4.6 & 5.8), 40 mM phosphate (pKa = 6.9 & 11.6), and 40 mM 
boric acid (pKa = 9.2).29  The pH of the Britton-Robinson buffer was adjusted using 0.2 M NaoH.  
BPACE buffer consists of 10 mM sodium phosphate, 10 mM boric acid, 10 mM sodium citrate 
and 1 mM EDTA at pH 7.0. 30  The pH of the BPACE buffer was adjusted with either 
ammonium hydroxide or 20% sulfuric acid.  The modified universal buffer consisted of boric 
acid, citric acid, maleic acid, Trizma base and sodium hydroxide.   The pH of the modified 
universal buffer was adjusted using 1.0 M HCl or 1.0 M NaOH.  Each of the mixtures were 
aliquoted into 10 tubes with 5 mL volume.  The aliquots were separately mixed with the 
corresponding pH adjusting solutions and the pH values of the resulting solutions were measured 
at room temperature using pH paper.  The pH paper was used because it was easier to test the 
small volumes of the buffer solutions using pH paper instead of a pH probe.  The aliquots were 
oxygenated overnight and then the pHs of the solutions were tested again to determine if they 
were stable the next morning.  If the pH of the solutions remained the same, 100 mM Glp, 1 mM 
ABTS and 600 nM HRP was added to each aliquot.  The activity of the MpGlpO wild-type 
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enzyme was analyzed from pH 3 to pH 10 by monitoring the increase in absorbance at 420 nm 
using the ABTS-HRP assay.    
 
3.2.7 EXPRESSION OF SSPGLPO  
Purification of the type I Streptococcus sp. GlpO wild type enzyme and the two catalytic 
base mutants H65Q & H65A will provide details on the function of the active-site His in type I 
vs type II GlpOs.  Understanding the role of the catalytic base in type I GlpOs such as 
Streptococcus sp. could also be useful in guiding further studies of other type I and type II 
GlpO/DH enzymes.  Test expressions of SspGlpO wild-type and mutant protein were performed 
using a wide variety of bacterial cell lines and media following established protocols.  The media 
contained 10 ug/mL tetracycline, 100 ug/mL ampicillin, and 30 mM glucose.  Growth of the 
media was at 37 oC until the optical density of the cells reached 1.0 and were then cooled in an 
ice bath before induction with 0.5 mM IPTG.  The cultures were kept at 23 oC for 7-10 hours 
before harvesting.  Wild-type protein expression was tested using XL1-Blue, B834/pREP4, 
HMS174, and BL21 bacterial cell lines.  Each of the cell lines were tested in LB, TYP, Terrific 
Broth, and auto-induction media in order to get expression of the correct protein band at 
approximately 65,000 Daltons.  Expression of the desired protein was analyzed using SDS-
PAGE gels.   
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CHAPTER 4.  RESULTS AND DISCUSSION 
 
4.1. EXPRESSION AND PURIFICATION OF HIS6-MPGLPO 
Recombinant wild-type MpGlpO, proposed catalytic base mutants H51Q and H51A, as 
well as mutant S348A were all expressed as soluble enzymes in E. coli BL21 cells cultured in 
Terrific broth and induced using IPTG at 25 oC.  MpGlpO wild type and mutants were purified 
using Ni-NTA affinity chromatography, SP-Sepharose cation exchange chromatography, and 
size exclusion gel chromatography as described in the Experimental section.  This protocol 
resulted in approximately 22, 11, 3, and 21 mg of purified enzyme for MpGlpO wild-type, 
MpGlpO H51Q, MpGlpO H51A, and MpGlpO S348A, respectively.  The size exclusion column 
helps determine if the protein elutes at the right size and that no aggregation is occurring, and 
with our enzyme eluting at the proper time as estimated by the column standards (Figure 13), we 
assume that the protein eluted as a monomer and is correctly folded (Figure 14).  The lambda 
max of the peak (MpGlpO ~ 47,348.62 daltons) shown in Figure 14 eluted at approximately 140 
mLs. The standard in Figure 13 that eluted at 145 mLs had a molecular weight of 44,000 daltons, 
therefore concluding that the MpGlpO wild-type protein eluted at the correct time should be 
properly folded.  There is a slight shoulder present in the chromatograph of wild-type enzyme, 
perhaps illustrating the formation of some dimers or other oligomers.  The purified enzyme 
exhibited spectral characteristics that are typical of a FAD-bound enzyme, with a maximum 
absorbance located at 448 nm and a 280:450 ratio of 6.5, which is consistent with other 
flavoenzymes (compared to 7.0 for the enzyme from E. casselifalvus).14   
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Figure 13: Standards of the size-exclusion column.  The molecular weights of the standards used 
are 670 kDa, 158 kDa, 44 kDa, 17 kDa and 1.3 kDa and they eluted at 92, 113, 145, 183, and 
293 minutes, respectively.  
 
 
Figure 14: This figure illustrates the chromatogram taken during the gel filtration column of 
MpGlpO wild-type.  The lambda max of the peak (MpGlpO ~ 47,348.62 daltons) shown eluted at 
approximately 140 minutes.  Because the enzyme is not elongated, we are able to use the 
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standards of the sizing column to estimate if the protein is aggregating together or if it eluting as 
a monomer.  Because the column standard at 44,000 daltons elutes at approximately 145 minutes 
it makes sense that MpGlpO elutes at about the same time if not a little faster.   
 
In order to ascertain that there were no dramatic structural changes caused by the His51 
and Ser348 mutations, the sizing column chromatogram of each enzyme was analyzed as it was 
being purified to see if it had the correct elution profile.  The H51Q, H51A (Figure 15), and 
S348A (Figure 16) proteins all eluted at approximately 135-141 minutes, concluding that the 
mutations had no substantial effects on MpGlpO folding.   
 
 
Figure 15: Chromatogram of mutant H51A of the gel filtration column.  The lambda max of the 
peak shown eluted at approximately 136 minutes.   
 
 
Figure 16: Chromatogram of mutant S348A of the gel filtration column.  The lambda max of the 
peak shown eluted at approximately 135 minutes. 
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4.2. ENZYME ASSAY 
The standard kinetic assay was performed in 50 mM sodium phosphate buffer, saturated 
oxygen substrate (approximately 0.26 mM), pH 7.0, at 25 oC typically containing 200 mM D-L-
Glp, 1 mM ABTS, and 600 nM HRP.  Specific activities of the enzymes were determined by 
multiplying the rate of the reaction by the volume of the reaction and then dividing by the mass 
of the total protein to give units of micromole*min-1*mg-1.  Using the ABTS-HRP coupled assay 
to monitor the increase of absorbance at 420 nm due to the oxidation of ABTS, the absorbance 
values were plotted against time (in seconds) in order to determine the initial velocity of the 
enzyme (Figure 17).  The initial velocity provides a rate for the enzyme prior to substantial 
substrate depletion and product accumulation.  The initial velocity is determined from the slope 
of the curve at the beginning of the reaction, when the reverse reaction is insignificant.16  The 
initial velocity of the reaction was divided by the molar absorption coefficient of ABTS (42.3 
mM-1*cm-1) in order to calculate the rate of the reaction in units of mM ABTS*min-1.  The 
specific activities of the wild-type enzyme, H51Q, H51A, and S348A mutants were determined 
to be 34.7 +/- 4.6 U*mg-1, 2.22 +/- 0.34 U*mg-1, 0.45 +/- 0.18 U*mg-1, and 0.62 +/- 0.22 U*mg-1 
respectively.  
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Figure 17: (A) Standard kinetic assay for wild-type, H51A, H51Q & S348A MpGlpOs monitored 
at 25 oC .  The assay reactions were monitored by the ABTS-HRP assay using a Cary UV/VIS 
spectrophotometer. The standard assay solution in oxygen-saturated 50 mM sodium phosphate 
buffer (pH 7.0) typically contained 100 mM Glp, 1 mM ABTS and 600 nM HRP at 25 oC.  The 
activity of the enzyme was measured by monitoring the increase in absorbance at 420 nm due to 
the oxidation of ABTS  (B) Re-plot of A to more easily see rate of MpGlpO mutants.  Our results 
show severely compromised activity when His51 or Ser348 is altered.   
 
Every time that one of the mutants’ specific activity was tested using the ABTS-HRP 
assay, MpGlpO wild-type was tested alongside it in order to make sure that the assay was 
working correctly each time.  Reactions of mutant and wild-type enzyme were tested in triplicate 
on one day and then repeated in triplicates on a separate day in order to verify the results.  The 
average of the slopes from the reactions were used in calculating the specific activity of the 
MpGlpO enzyme.   
Mutation of either the His51 or Ser348 residue severely compromised enzyme activity.  
The H51Q mutation was 6.5% as active as wild-type, while H51A was approximately 1.3% as 
active as wild-type.  It is also important to note that the activity of H51Q was higher than H51A 
in Figure 17B.  Through site-directed mutagenesis, the active-site histidine was replaced with 
alanine in order to assess the contribution of the side chain in forming hydrogen bonds with the 
glycerophosphate substrate.  Based on our data it would lead us to believe that the polar side 
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chains of amino acids histidine and glutamine, that are absent in alanine, are important for 
hydrogen bonding with the substrate. However, if His51 were the true catalytic base, any 
mutation would result in the enzyme having less than 1% of wild-type activity remaining, which 
leads us to believe His51 may be more important for substrate recognition than as a catalytic 
base.  Our results illustrate that the reaction can still proceed without a catalytic base, with the 
H51Q mutation retaining 6.5% of wild-type activity.  Recent studies have shown that naturally 
occurring flavins can act as stand-alone catalysts in aqueous buffer.31  The study compared the 
catalytic activity of FMN alone with that of NRPS oxidase EpoB-OX.  Under matching 
conditions, kinetic parameters for FMN and EpoB-OX were determined resulting with similar 
Km values of 1.1 +/- 0.1 mM and 2.1 +/- 0.4 mM for FMN and EpoB-OX respectively.31  
However the rate constant for FMN (kcat = 0.47 +/- 0.04 min-1) was an order of magnitude lower 
than that for EpoB-OX (kcat = 7.7 +/- 0.8 min-1).31  This evidence suggests that the oxidase may 
contain a base in the active site that causes greater catalytic efficacy when compared to FMN 
alone, however the reaction is still able to proceed solely with the flavin.  It is likely that EpoB-
OX enzyme is able to bind both the flavin and the substrate within close proximity, helping to 
facilitate the reaction, while the reactions catalyzed by the FMN by itself require productive 
collisions of the flavin with the substrate in solution.  A possible residue that could be assisting 
the His51 mutants in forming hydrogen bonds with the substrate is Ser348, which is conserved in 
all 72 MpGlpO relatives.13  Ser348 is within the distance needed for hydrogen bond contacts of 
the modeled Glp substrate C2-hydroxyl as seen in Figure 11.  The serine hydroxyl group is able 
to form hydrogen bonds with a variety of polar substrates,32 which could allow them to assist the 
His51 mutants in recognizing the proper substrate.  Mutation of the Ser348 mutant to alanine 
also resulted in approximately 2% of wild-type activity, concluding that the hydroxyl group on 
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serine, and any hydrogen bonds that would be formed, are important for substrate recognition 
and catalysis.   
 
4.3. STEADY-STATE KINETICS 
Apparent steady state kinetics of MpGlpO wild type using saturated oxygen and Glp as 
substrates were investigated at 25 oC, pH 7.0, using the 2,2’-azino-bis(3-ethylbenzothiazoline-6-
sulfonic acid)/horseradish peroxidase (ABTS/HRP) assay as described in the Experimental 
section.  Initial rates at various concentrations of glycerophosphate were measured.  Kinetic 
parameters of the enzyme reaction obtained from a direct Michaelis-Menten or Hanes-Woolf plot 
(Figure 18) were KmGlp = 14 +/- 2.3 mM, Kcat = 75 +/- 3.6 s-1, resulting in a specificity constant 
of 5.3 mM-1*s-1.  This specificity constant is similar to the previously reported Kcat/Km of 5 mM-
1s-1 by Maenpuen et al.  
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Figure 18: Apparent steady-state kinetic parameters of wild-type MpGlpO at 25 oC.  Initial rates 
obtained from various concentrations of Glp (0.1 mM – 102.4 mM) were measured, and plotted 
using [Glp]/Vo versus [Glp].  Kinetic parameters were determined using the equation 
[S]/V=(1/Vmax*[S])+Km/Vmax.    
 
The kcat of 75 s-1 seems to be on par with other oxidases, comparable to that seen for 
GlpOs from E. casseliflavus14 and Streptococcus sp.15 which gave kcat values of 70-90 s-1 at 25 
oC.  Due to the low specific activity of the mutants during the standard assay that uses 200 mM 
Glp, full kinetic traces of the mutants were attempted but produced no reliable data.  Steady-state 
kinetics of the H51Q mutant were performed at enzyme concentrations of 5.16 nM, 51.6 nM, 
103.2 nM, 206.4 nM, 412.8 nM and 825.6 nM using a range of 100 mM to 500 mM Glp 
substrate.  Unfortunately, we were still unable to determine a Vmax at these high enzyme 
concentrations, indicating that the rate of the reaction is too low or that the Km of the mutant is 
too high in order to obtain a full kinetic trace.   
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4.4. SULFITE TITRATION ASSAY 
Many flavoprotein oxidases are characterized by their ability to react with sulfite and 
form a reversible adduct at the flavin N5-position.27  The flavin-sulfite adduct is stabilized by 
interactions with many residues at the active site as indicated by a structural study of 
flavocytochrome b2 complexed with sulfite, including the active-site histidine and serine 
residues.33  Type I GlpOs including EcassGlpO and SspGlpO give similar values of Kd = 0.82 
mM and 1.5 mM14,15 and in both enzymes the flavin becomes fully reduced with sulfite.  In this 
study, we performed titrations using a similar protocol with freshly prepared MpGlpO.  For wild-
type MpGlpO, our titrations with sulfite provided a Kd = 3.3 mM, which is similar to the 3.0 mM 
Kd that was determined by a previous study.13  Additionally, MpGlpO showed that its flavin 
absorption was only bleached by about 50%, through the addition of sulfite (Figure 19), which 
also agrees with the sulfite titrations previously reported on MpGlpO.13  As of this moment we 
do not have a clear idea as to why only half of the enzyme reacts with sulfite.  We can speculate 
that perhaps the inactive species is the result of nonproductive site architecture (nonproductive 
for FAD binding or sulfite adduct formation). Another possibility could be that some 
oligomerization is occurring, as seen in the very slight shoulder present in the size exclusion 
chromatograph (Figure 14), and the species of MpGlpO that is forming dimers are unable to bind 
with sulfite.  None of the other GlpO enzymes previously described show this behavior in sulfite 
titrations.  Unfortunately, a sulfite titration with H51A mutant was unable to be performed due to 
low protein yield from purification and will need to be done for future work in this area.   
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Figure 19: (A) Sulfite titrations of MpGlpO wild-type.  35.4 micromolar of wild-type was titrated 
aerobically with a 1 M sodium sulfite solution, and flavin reduction was monitored after each 
addition of sulfite.  The spectra shown correspond to the addition of 0 mM (dark blue), 3.33 mM 
(red), 10 mM (green), 20 mM (purple), 30 mM (light blue), 40 mM (orange) and 50 mM (gray).  
(B): Abs450 as a function of added sulfite.  The line represents the least square fitted behavior 
for a 1:1 complex formation of enzyme:enzyme-sulfite.     
 
When the H51Q mutant was titrated with sulfite, less than 5% of the enzyme reacted with 
sulfite (Figure 20) and the calculated Kd for the H51Q mutant was approximately 300 mM. a one 
hundred-fold increase compared to the wild-type enzyme.  We believe that the reduced adduct 
formation and the increase in the Kd indicates that the histdine residue contributes significantly to 
the formation of the FMN-sulfite adduct.    Elkhal et al. proposed that the His51 and Ser348 
residues are in a close enough position that allows for efficient adduct formation.13  These 
differences are likely due to the absence of favorable interactions with the histidine side chain 
and steric factors in the mutation with a glutamine.34  One possible hypothesis that explains why 
roughly half of the enzyme forms the reversible sulfite adduct is the existence of two species of 
enzyme during the reaction, one fast-reacting species and one slow-reacting species, which is 
seen in Table 2.  It is possible that the slow-reacting species is unable to form the sulfite adduct.  
The crystal structure paper on MpGlpO wild-type published by Elkhal et al.  also witnessed a 
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50% in absorbance upon titration with sulfite, but they were unable to offer any explanations as 
to why only half of MpGlpO reacts with sulfite.   
 
 
Figure 20: Sulfite titrations of MpGlpO mutant H51Q.  35.4 micromolar of mutant enzyme was 
titrated aerobically with a 1 M sodium sulfite solution, and flavin reduction was monitored after 
each addition of sulfite.  The spectra shown correspond to the addition of 0 mM (dark blue), 3.33 
mM (red), 10 mM (green), 20 mM (purple), 30 mM (light blue), 40 mM (orange) and 50 mM 
(gray).   
 
Titration of the serine mutant with sulfite (Figure 21) led to behavior like neither the 
wild-type nor the histidine mutant.  The serine mutant becomes fully reduced upon titration with 
sulfite, whereas only half of the MpGlpO enzyme reacted with sulfite.  Plotting the absorbance at 
450 nm versus sulfite concentration concluded that the Kd for the S348A mutant was 
approximately 6 mM, which is two-fold higher than the Kd of wild-type.  The slight increase in 
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Kd of the Ser348 also illustrates that the residue is contributing to the sulfite-adduct formation.  
These differences in the FMN-sulfite adduct spectra of the S348A mutant indicate that the 
Ser348 residue plays a role in only half of the FAD being reduced in wild-type enzyme.  Because 
of the close proximity of the Ser348 residue with the flavin, the oxygen atom from Ser348 is 4.6 
Å away from the flavin N5-atom, the amino acid could have a role in formation of the sulfite 
adduct.   
 
 
Figure 21: Sulfite titrations of MpGlpO mutant S348A.  35.4 micromolar of mutant enzyme was 
titrated aerobically with a 1 M sodium sulfite solution, and flavin reduction was monitored after 
each addition of sulfite.  The spectra shown correspond to the addition of 0 mM (dark blue), 3.33 
mM (red), 6.67 mM (green), 10 mM (purple), 20 mM (light blue), 30 mM (orange) and 40 mM 
(gray) and 50 mM (pink).   
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It is possible that the His51 residue directly contributes to the binding of the sulfite 
adduct, while the Ser348 residue observed in type II GlpOs while not available in type I, plays an 
important role in the observed changes in redox potential by affecting the flavin electrostatic 
environment that impairs the ability of half of the enzyme to bind.  SspGlpO illustrates full 
sulfite reduction and does not have the Ser residue available in the active site of the enzyme, 
instead of the Ser residue SspGlpO has a Lys residue in its active site.4  This change from the 
positively charged lysine in type I GlpOs to the neutral charged side chain serine in the type II 
MpGlpO could result in the two varying sulfite-adduct formations of the type I and type II 
enzymes.    
 
4.5. PH TITRATION USING MULTI-BUFFER SYSTEMS 
Attempts at determining the pKa of the important catalytic residues were done using a pH 
titration.  The activity of the MpGlpO wild-type enzyme was analyzed from pH 3 to pH 10 by 
monitoring the increase in absorbance at 420 nm due to oxidation of the ABTS.  A plot of 
activity vs pH of buffer (Figure 22) illustrates that the wild-type enzyme exhibits different 
activities at different pH values.  This leads us to believe that the protonation state of the 
histidine in the active site could be important for proper substrate recognition.  Because the low 
pHs tested exhibited little to no activity when compared to pH 7.0 or higher, it leads us to believe 
that a deprotonated histidine is essential for hydrogen bonding with the substrate.  However, 
attempts at repeating the experiment was unsuccessful as the lower pH buffer solutions failed to 
hold after the substrate was added to the assay solution.  It is unclear why the buffer held at the 
proper pH the first time and unable to hold on following attempts.  The first attempt at the pH 
titration illustrates that the pKa of the active site in MpGlpO is between 6 and 8, and we would 
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expect that value to correspond with perhaps histidine which has a side chain pKa of 6.04 and a 
pI of 7.58.   
 
 
Figure 22: pH titration of MpGlpO wild-type enzyme using Britton Robinson Buffer, at 25 oC, at 
various pHs to test specific activity.  Specific activity was determined by monitoring the reaction 
at 420 nm using the ABTS-HRP coupled assay previously described.   
 
If a buffer-system that holds at low pHs upon addition of the glycerophosphate substrate 
could be found, a pH titration of the wild-type enzyme would be useful in determining the pKa of 
the active site of MpGlpO.     
 
4.6. EXPRESSION OF SSPGLPO  
Sufficient growth was seen following a protocol suggested by Dr. Derek Parsonage 
(Wake Forest University) in each of the tested media, but after running a SDS-PAGE gel on 
samples before and after induction, there was no evidence of production of the correct protein.  
Attempts at purification of SspGlpO wild-type enzyme were also performed, resulting in SDS-
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PAGE gels with multiple bands appearing in the pooled fractions, instead of one band at the 
correct size, illustrating a potential proteolysis (Figure 23).   
 
 
Figure 23: SDS-PAGE gel of SspGlpO protein fractions after Q column (cation exchange).  The 
ladder used is Precision Plus Protein Standards and are listed to the left of the corresponding 
band in the figure.  The fraction number is labeled above the corresponding lane.   
 
Previous studies have shown that the H65Q mutation in SspGlpO retains 63% of wild-
type activity, unlike the H51Q mutation in MpGlpO which results in approximately 7% of wild-
type activity.  However, the data involving SspGlpO His65 mutations was acquired from a well 
plate and need the experiments need to be performed using a different instrument to verify the 
results.  It is important to note that the same substitution in the two enzymes result in vastly 
different activities and understanding the differences between the type I and type II enzymes will 
be useful in figuring out why this happens.  The H65Q mutation in SspGlpO retained 
approximately 63% of wild-type activity while the H65A mutation only had 2% of activity 
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remaining.  Although the H51A mutation only had 1.3% of wild-type activity, comparable to the 
2% of wild-type activity of H65A in SspGlpO.  It could be possible that in SspGlpO there is a 
nearby residue that can assist the glutamine residue in establishing catalytic activity when the 
histidine is mutated into a glutamine, however when the histidine is mutated into an alanine then 
almost no activity is seen.  One possibility that explains these results is that the polar charge that 
is seen in both histidine and glutamine, but not alanine, is necessary for efficient catalytic 
activity.  It is also possible that the residues must be able to act as hydrogen bond donors in order 
to establish catalytic activity, or that the mutations of the residues are no longer sterically ideal to 
be able to interact with the glycerophosphate substrate.   
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CHAPTER 5.  CONCLUSIONS AND FUTURE WORK 
  
In conclusion, we have confirmed that His51 is important in hydrogen bonding to the Glp 
substrate.  Based on the model shown in Figure 9, His51 could function as a hydrogen bond 
donor or acceptor from the C2 of Glp.  It could be possible that a water molecule is acting as the 
base in the reaction, with the His51 residue being essential for recognition of the substrate.  
Using the specific activity determined from the ABTS-HRP coupled assay we have concluded 
that mutation of this residue to a glutamine or an alanine results in compromised activity when 
compared to wild-type, illustrating its important role in the catalytic activity of the MpGlpO 
enzyme.  Mutations of the Ser348 residue with an alanine also results in severely reduced 
activity of the MpGlpO enzyme providing strong support for the model of Glp binding presented 
in Figure 9.  This work suggests that the Ser 348 residue influences the redox potential of the 
flavin, as mutations of this amino acid causes the flavin to become completely reduced during 
sulfite titrations.  Future work in this area will focus on determining the Flavin redox potential in 
the mutants.  Apparent steady-state kinetics at 25 oC and pH 7.0 revealed that the wild-type 
enzyme has a KmGlp of 14 mM and a Kcat of 75 s-1, resulting in a specificity constant of 5.3 mM-
1*s-1.  The specific activity of the wild-type enzyme and H51Q, H51A, and S348A mutants were 
determined to be 34.7 U*mg-1, 2.22 U*mg-1, 0.45 U*mg-1, and 0.62 U*mg-1, respectively.  The 
fact that H51Q has slightly more activity than H51A leads to the conclusion that a polar side 
chain is necessary for efficient conversion of substrate to product through the use of hydrogen 
bonding with the polar residue.  The data demonstrates that the His side chain is important, as a 
simple substitution to another polar side chain does not restore wild-type activity levels.  Sulfite 
titrations also revealed the importance of His51 in the ability of MpGlpO to form the sulfite-
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adduct, and a completely different sulfite profile than wild-type when the Ser348 residue is 
mutated.  It is likely that mutations of the Ser348 residue causes a change in the redox potential 
between the type I and type II GlpOs.  In the S348A mutant the flavin becomes fully reduced 
upon titration with sulfite, revealing that in this mutant the flavin more readily receives electrons.  
It is also likely that the H51Q mutation causes the enzyme to no longer be able to efficiently bind 
to sulfite and the His residue is necessary for sulfite-adduct formation.   
Future work to be done with the MpGlpO enzyme will be to complete the mutations for 
the rest of the amino acids located in the active site that are predicted to bind the substrate.  In 
particular we are interested in mutating R320, K258, F250, S47, and Y234, which are shown in 
Figure 6.  Mutant K258M has already been harvested following the established protocol. The 
R320M mutant was not obtained, to date, and requires resequencing.  The K258M mutant has 
been sequenced and expressed and is ready for protein purification.  It could also be of interest to 
perform a double mutation, a H51AS348A mutation of both critical residues in the active site to 
see if the resulting enzyme, assuming it would be properly folded, would retain any wild-type 
activity.   
Using the predicted binding model from Elkhal et al., the roles of the amino acids in the 
active site of the enzyme are able to be predicted based on their location and composition of the 
residue (Figure 10A).  Arg320 is predicted to be involved in electrostatic/hydrogen-bonding 
interactions with the phosphoryl group on the Glp substrate.  Arg320 is conserved in all 72 close 
relatives of MpGlpO.  Lys258 is also conserved in all 72 relatives of MpGlpO and is predicted to 
interact with the phosphoryl group on Glp. Phe250 is conserved in all 72 MpGlpO relatives and 
is predicted to help stabilize the C1 hydroxymethyl group on the glycerol domain of 
glycerophosphate.  Ser47 is predicted to interact with both a hydroxyl on Tyr234 as well as the 
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flavin cofactor.  Ser47 is conserved in 70 MpGlpO relatives and replaced, conservatively by Thr 
in two.  Mutating the Ser47 residue with an alanine would disrupt the interactions with the 
Tyr234 hydroxyl and FAD.  The Tyr234 mutation would test the importance of its interaction 
with Ser47.  The Ser47 hydroxyl, supported by its interactions with Tyr234, is well placed to 
help stabilize the protonated N5 of the reduced flavin.13  This could provide further insight into 
the catalytic mechanism of MpGlpO and help illustrate the differences between the type I and 
type II GlpOs.  Out of the previously mentioned residues, R320 is conserved in type I and type II 
GlpOs, while Ph3250, Ser47 & Tyr234 are replaced by similar residues in type I GlpOs, and 
there is no Lys258 equivalent in SspGlpO (Figure 6C).  It would also be of interest to obtain the 
crystal structure of the wild-type MpGlpO enzyme with the glycerophosphate substrate bound in 
an attempt to validate the binding mechanism.  Acquiring a stopped-flow instrument to perform 
enzyme-monitored turnover experiments in order to understand the rate-limiting steps of my 
mutants.  This will be accomplished by monitoring the reductive and oxidative half-reactions to 
see where the mutants are impacting the activity of the enzyme.   
It would likewise be of interest to pursue attempts at chemical rescue of the H51A mutant 
using imidazole.  Illustrating that the addition of imidazole, which has a structure closely related 
to a histidine side chain, rescues the activity of the enzyme would further prove the importance 
of the histidine side chain in the activity of MpGlpO wild-type.  The H51A mutant protein 
activity was measured in the same conditions as the standard assay with varying concentrations 
of imidazole.  Imidazole concentrations were varied from 0 to 100 mM and were added to the 
assay mixture from concentrated stocks adjusted to pH 7.0.  However, the imidazole rescue 
resulted in being unable to obtain any measurable change in the rate of the enzyme with varying 
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concentrations of imidazole.   Further study in order to determine if rescue of activity is 
achievable using a higher concentration of enzyme than previously attempted. 
Another topic that could be of interest as a future goal would be to continue to try to 
determine the pKa of the active site of MpGlpO using pH titrations.  Revealing the pKa of the 
active site could shed some light on the residues in the active site that could be assisting His 51 
in acting as the catalytic base in the MpGlpO reaction.  Finding a multi-buffer system that holds 
at low pHs when the glycerophosphate is added is necessary for determining the pKa of the active 
site of MpGlpO.  One caveat however, is that there is a possibility of the protein becoming 
misfolded at the low pH regions.  In order to verify that the enzyme has not altered its folding 
pattern would be to look at the fingerprint region of the flavin using Infrared spectroscopy before 
and after varying the pH values.  It could also be possible to make sure the protein keeps its 
folding pattern at low pH values using circular dichroism spectroscopy to see if the percentage of 
alpha-helices and beta-sheets differs upon changing the pH.    
The last future goal for this study would be to establish a protocol to obtain successful 
expression of SspGlpO in order to verify the results obtained from our collaborators.  If the type I 
GlpO SspGlpO truly retains 63% of wild-type activity, it would be likely that the two types of 
GlpOs utilize different catalytic mechanisms.  If type I and type II GlpOs utilize different 
mechanisms it could be possible to develop small molecule inhibitors against MpGlpO for future 
drug development against Mycoplasma pneumoniae infections.   
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